Novo Nordisk
NVO
#16
Rank
S$662.67 B
Marketcap
$144.35
Share price
-1.53%
Change (1 day)
11.45%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2023 (TTM): $3.85

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is $3.85. In 2022 the company made an earnings per share (EPS) of $2.93 an increase over its 2021 EPS that were of $2.69.

EPS history for Novo Nordisk from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.8531.37%
2022$2.939.01%
2021$2.6915.08%
2020$2.3414.83%
2019$2.03-1.68%
2018$2.074.96%
2017$1.9731.08%
2016$1.50-10.33%
2015$1.6813.91%
2014$1.474.03%
2013$1.41-28.81%
2012$1.99108.9%
2011$0.9525.59%
2010$0.7635.01%
2009$0.56-9.17%
2008$0.6261.35%
2007$0.3828.96%
2006$0.3025.63%
2005$0.244.17%
2004$0.2313.55%
2003$0.2036.87%
2002$0.15-6.99%
2001$0.1621.56%
2000$0.1349.45%
1999$0.086383.78%
1998$0.0832312.15%
1997$0.0742124.74%
1996$0.05949

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.51-34.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.33 90.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.36 39.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.29 11.36%๐Ÿ‡ซ๐Ÿ‡ท France